Consequently, the expression of several β-catenin target genes decreases, including Axin2, Lgr5, Cd44, Birc5, and c-myc, indicating that CCAR1 functions in the same way in gastric cancer cells as it does in colon carcinoma cells. This evidence concerns the gene CCAR1 and colon carcinoma.